5% Diclofenac Sodium Jekiseni yekushandiswa kwemhuka

Composition

Imwe neimwe ml ine Diclofenac Sodium 50mg

Properties:

Diclofenac sodium, sodium 2- [(2,6-dichlorophenyl) amino] phenylacetate imwe yezvisiri-steroidal anti-inflammatory drugs (NSAIDs), ndeye phenyl acetic acid derivatives.Diclofenac sodium se anti-inflammatory, analgesic uye antipyretic madhara inokonzerwa nekuderera kweprostaglandin synthesis kubva arachidonic acid nekudzivisa cyclo-oxygenase.Mhedzisiro yaro ndeye 2 ~ 2.5 nguva yakasimba kupfuura indomethacin uye 26 ~ 50 nguva yakasimba kudarika acetylsalicylic acid.Inoratidzwa nekushanda kwezvinodhaka kwakasimba, maitiro asina kunaka, maduku maduku, uye kusiyana kuduku kwemunhu.

Kusungirirwa kwemushonga kune plasma protein ndeye 99.7%.Hafu yehupenyu ndeye 1 kusvika maawa maviri.Zvinoenderana neinokurudzirwa dose uye kupindirana, hapana kuunganidza.Mushonga unogadziriswa nechiropa, uye inenge 60% yehuwandu hwekurapa hwemetabolites hunobudiswa kubva kuitsvo, uye kubuda kwechirwere chepakutanga kunopfuura 1%.Imwe yakasara yedosi iri muchimiro chemetabolites, inobuditswa muura kuburikidza nebile, uye inocheneswa kubva mutsvina.

Zviratidzo

Antipyretic analgesics.Diclofenac sodium jekiseni se-anti-inflammatory uye analgesic, inoratidzwa nokuda kwekutonga kwemarwadzo nekuputika kunobatanidza ne musclo-skeletal disorders se;arthritis, osteoarthritis, osteochondritis, bursitis, tendenitis uye myositis, acute pneumonia, acute mastitis uye enteritis.

Inoshandiswawo kudzora fivha yakabatana nehutachiona kana kupera kwenyama mumhando dzakasiyana dzemhuka.

Dosage uye Administration

Intramuscular injection:

imwe dose, 1.25mg pa1kg uremu hwemuviri;

mhuka dzinoramba dzichishandiswa 1-3 mazuva.

Zvekungwaririra:Inofanira kubaiwa zvishoma nezvishoma.

Storage: Chengetedza munzvimbo inotonhorera, yakaoma uye ine rima.Chengetedza pasingasvikirwi nevana.

Hebei Veyong Pharmaceutical Co., Ltd, yakavambwa muna 2002, iri muShijiazhuang City, Hebei Province, China, padyo neguta guru Beijing.Iye ihombe GMP-yakasimbiswa veterinary drug bhizinesi, ine R&D, kugadzira uye kutengesa kweVeterinary APIs, gadziriro, premixed feed uye feed additives.SeProvincial Technical Center, Veyong yakamisa hurongwa hweR&D hwemishonga mitsva yezvipfuyo, uye ndiyo inozivikanwa pasi rose tekinoroji innovation yakavakirwa bhizinesi rezvipfuyo, kune makumi matanhatu neshanu nyanzvi.Veyong ine mabhesi maviri ekugadzira: Shijiazhuang neOrdos, iyo iyo Shijiazhuang base inovhara nzvimbo ye78,706 m2, ine 13 API zvigadzirwa zvinosanganisira Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, uye 11, gadziriro yekugadzira oral poda, mitsara yekugadzira oral. , premix, bolus, mishonga yezvipembenene nemishonga inouraya utachiona, ects.Veyong inopa APIs, anopfuura zana ega- label gadziriro, uye OEM & ODM sevhisi.

Veyong inokoshesa zvikuru manejimendi eEHS(Environment, Health & Safety) system, uye yakawana ISO14001 uye OHSAS18001 zvitupa.Veyong yakanyorwa mumabhizinesi ari kusimukira maindasitiri muHebei Province uye inogona kuve nechokwadi chekuenderera mberi kwezvigadzirwa.

Veyong yakamisa hurongwa hwekutonga kwemhando yakakwana, yakawana chitupa cheISO9001, chitupa cheChina GMP, chitupa cheAustralia APVMA GMP, chitupa cheEthiopia GMP, chitupa cheIvermectin CEP, uye yakapasa ongororo yeUS FDA.Veyong ine timu yehunyanzvi yekunyoresa, kutengesa uye tekinoroji sevhisi, kambani yedu yakawana kuvimba nerutsigiro kubva kune akawanda vatengi nemhando yepamusoro yechigadzirwa, yepamusoro-yemhando yepamusoro-yekutanga kutengesa uye mushure mekutengesa sevhisi, yakakomba uye yesainzi manejimendi.Veyong yaita kushandira pamwe kwenguva refu nemabhizinesi mazhinji anozivikanwa pasi rose emishonga yemhuka ane zvigadzirwa zvinotengeswa kuEurope, South America, Middle East, Africa, Asia, etc. kupfuura nyika makumi matanhatu nematunhu.